Related Experiment Videos
How useful are implantable cardioverter-defibrillators?
1Electrophysiology Laboratory, Allegheny General Hospital, Pittsburgh, PA 15212.
Postgraduate Medicine
|July 1, 1992
Summary
Carefully weigh implantable cardioverter-defibrillator (ICD) risks and benefits. New studies are crucial to document ICD efficacy in lower-risk patients as technology advances.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Implantable cardioverter-defibrillators (ICDs) treat life-threatening ventricular arrhythmias.
- Careful risk-benefit assessment is crucial before ICD implantation.
- Perioperative risks vary by patient selection and medical center.
Purpose of the Study:
- To highlight the importance of documenting ICD usefulness, especially in evolving clinical practice.
- To address the need for adequate studies in lower-risk patient groups.
- To emphasize the transition of ICDs towards broader application.
Main Methods:
- Review of current practices and challenges in ICD implantation.
- Discussion of the limitations of suboptimal methods for documenting ICD benefit.
- Recognition of the role of randomized controlled trials (RCTs) in evaluating new patient groups.
Main Results:
- Perioperative risk for ICD implantation is influenced by patient selection and center-specific factors.
- Documenting the efficacy of ICDs in lower-risk patients presents challenges.
- Increased use of ICDs in lower-risk groups necessitates robust evidence.
Conclusions:
- Thorough patient selection and center-specific data are vital for minimizing ICD implantation risks.
- Advanced study methodologies, including RCTs, are essential for validating ICD efficacy in broader patient populations.
- Ongoing research is critical to ensure appropriate and effective use of ICD technology.